Immunotherapy, as a novel treatment, has brought new hope to many patients with cancer, including patients with lung cancer. However, the overall cure rate and survival rate of lung cancer are still not satisfactory. The process of evolution has improved the ability of tumors to adapt to immunotherapy, which induces drug resistance. Many studies have focused on immunoresistance and achieved meaningful results. Therefore, it is necessary to have an in-depth understanding of the current research progress in immunoresistance, which will help to achieve good clinical results more efficiently.

中文翻译：

---

免疫疗法背景下肺癌的演变

免疫疗法作为一种新颖的治疗方法，为包括肺癌在内的许多癌症患者带来了新希望。但是，肺癌的总治愈率和存活率仍然不能令人满意。进化过程提高了肿瘤适应免疫疗法的能力，从而诱导了耐药性。许多研究集中在免疫抵抗上，并取得了有意义的结果。因此，有必要深入了解免疫抵抗的最新研究进展，这将有助于更有效地获得良好的临床效果。